Medlive Technology Co., Ltd. (HKG:2192)
7.06
+0.26 (3.82%)
Sep 11, 2026, 4:08 PM HKT
Medlive Technology Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Medlive Technology stock has a consensus rating of "Strong Buy" and an average price target of $12.11. The average 1-year stock price forecast is 71.53% higher than the current stock price, while the lowest is $10.23 (+44.90%) and the highest is $17.34 (+145.61%).
Price Target: $12.11 (+71.53%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Medlive Technology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 5 | 5 | 5 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst CICC No rating | CICC | Buy Maintains $10.50 | Buy | Maintains | $10.50 | +48.73% | Sep 2, 2026 |
Unknown Analyst HSBC No rating | HSBC | Buy Maintains $12.00 | Buy | Maintains | $12.00 | +69.97% | Jul 22, 2026 |
Unknown Analyst Citic Securities No rating | Citic Securities | Buy Maintains $17.00 | Buy | Maintains | $17.00 | +140.79% | Apr 13, 2026 |
Unknown Analyst Guotai Haitong No rating | Guotai Haitong | Buy Maintains $10.90 | Buy | Maintains | $10.90 | +54.39% | Mar 31, 2026 |
Financial Forecast
Revenue This Year
712.90M
from 642.16M
Increased by 11.02%
Revenue Next Year
821.27M
from 712.90M
Increased by 15.20%
EPS This Year
0.50
from 0.46
Increased by 7.02%
EPS Next Year
0.56
from 0.50
Increased by 13.28%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.